Literature DB >> 19003557

Cross-talk between IFN-alpha and TGF-beta1 signaling pathways in preneoplastic rat liver.

María De Luján Alvarez1, Ariel D Quiroga, Juan P Parody, María Teresa Ronco, Daniel E Francés, Cristina E Carnovale, María Cristina Carrillo.   

Abstract

Interferon-gamma/transforming growth factor-beta (IFN-gamma/TGF-beta) pathways have opposite effects on diverse cellular functions. However, little is known about interactions between IFN-alpha/TGF-beta. In previous studies, we showed that IFN-alpha2b increases TGF-beta(1) production and secretion in hepatocytes from preneoplastic rat livers. Here, the interaction between IFN-alpha/TGF-beta(1) pathways was explored. We observed a positive cross-talk between IFN-alpha and TGF-beta(1) signaling, with activation of both pathways. p300 protein levels in hepatocytes from preneoplastic livers were enough to interact with both activated Stat1 and Smad2/3. Besides, Smad7 was not directly related with TGF-beta(1) and IFN-alpha signals. Interestingly, we reported the novel finding that the autocrine TGF-beta(1) up-regulates TGF-betaRII at protein and mRNA levels. In conclusion, the intracellular signals triggered by IFN-alpha2b and by autocrine TGF-beta(1) are integrated at the nuclear level, where activated Stat1 and Smad2/3 are capable of interact with p300, present in no restrictive cellular amounts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19003557     DOI: 10.1080/08977190802547357

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  5 in total

1.  FoxO3a nuclear localization and its association with β-catenin and Smads in IFN-α-treated hepatocellular carcinoma cell lines.

Authors:  María Paula Ceballos; Juan Pablo Parody; Ariel Darío Quiroga; María Laura Casella; Daniel Eleazar Francés; María Cecilia Larocca; Cristina Ester Carnovale; María de Luján Alvarez; María Cristina Carrillo
Journal:  J Interferon Cytokine Res       Date:  2014-06-20       Impact factor: 2.607

2.  Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.

Authors:  Minghua Wu; Brian Skaug; Xiongjie Bi; Tingting Mills; Gloria Salazar; Xiaodong Zhou; John Reveille; Sandeep K Agarwal; Michael R Blackburn; Maureen D Mayes; Shervin Assassi
Journal:  Ann Rheum Dis       Date:  2019-08-22       Impact factor: 19.103

3.  Comparative study of the effects of PEGylated interferon-α2a versus 5-fluorouracil on cancer stem cells in a rat model of hepatocellular carcinoma.

Authors:  Tarek Kamal Motawi; Noha Ahmed El-Boghdady; Abeer Mostafa El-Sayed; Hebatullah Samy Helmy
Journal:  Tumour Biol       Date:  2015-08-26

4.  A genetic screen identifies interferon-α effector genes required to suppress hepatitis C virus replication.

Authors:  Dahlene N Fusco; Cynthia Brisac; Sinu P John; Yi-Wen Huang; Christopher R Chin; Tiao Xie; Hong Zhao; Nikolaus Jilg; Leiliang Zhang; Stephane Chevaliez; Daniel Wambua; Wenyu Lin; Lee Peng; Raymond T Chung; Abraham L Brass
Journal:  Gastroenterology       Date:  2013-02-24       Impact factor: 22.682

Review 5.  The Essential Role of Type I Interferons in Differentiation and Activation of Tumor-Associated Neutrophils.

Authors:  Ekaterina Pylaeva; Stephan Lang; Jadwiga Jablonska
Journal:  Front Immunol       Date:  2016-12-21       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.